Jacob R. Lang, OD, FAAO

A rapid-fire, top-level review of what happened in optometry in 2023.

CSF-1 (0.4% pilocarpine HCl), a presbyopia-correcting drop candidate from Orasis, demonstrated consistent pupil restriction, which also suggests neuroadaptation in patients with presbyopia to the drop over time.

Jacob R. Lang, OD, FAAO, highlights his Vision Expo West presentation,"An update on systemic conditions and medications you must look out for in OSD management."

Vin Dang, OD, FAAO, and Jacob Lang, OD, FAAO, speak on the highlights and key takeaways from their AOA 2022 lecture titled "Ocular surface preservation for the glaucoma patient."

Many systemic conditions have higher incidence with depression, anxiety

Corneal filaments frequently recur after removal, and resolution occurs only by treating the patient’s underlying inflammation. This case illustrates the need to move to atypical therapies, such as N-acetylcysteine.